English
简体中文
Total: £ 56.28
Published Date: 2026-02-06 | Pages: 113 | Tables: 113 | Medical Care
The global Bulk-Drug Compounding market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Bulk-drug compounding refers to the process of creating medications by combining, mixing, or altering ingredients to tailor a drug specifically for an individual patient's needs. This is typically done by licensed pharmacists or physicians when commercially available medications are unsuitable for a patient. It plays a crucial role in addressing specific medical conditions that require unique formulations or dosages.
The North American market for Bulk-Drug Compounding is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Bulk-Drug Compounding is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Bulk-Drug Compounding in Prescription Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Bulk-Drug Compounding include Fogron, B.Broun Melsungen AG, Nephron Pharmaceuticals Corporaiton, Athenex Pharmaceutical Division, QuVa Pharma, Fresenius Kabi, Central Admixture Pharmacy Services Inc, PharMEDium, Avella Speciality Pharmacy, ImprimisRx, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Bulk-Drug Compounding market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bulk-Drug Compounding. The Bulk-Drug Compounding market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bulk-Drug Compounding market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bulk-Drug Compounding manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Fogron
B.Broun Melsungen AG
Nephron Pharmaceuticals Corporaiton
Athenex Pharmaceutical Division
QuVa Pharma
Fresenius Kabi
Central Admixture Pharmacy Services Inc
PharMEDium
Avella Speciality Pharmacy
ImprimisRx
Edge Pharma
SCA Pharma
New England Compounding Center
Bellevue Pharmacy
Pharmazone
Segment by Type
Sterile Compounding
Non-sterile Compounding
Segment by Application
Prescription Drugs
Over-the-Counter Drugs
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Bulk-Drug Compounding companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bulk-Drug Compounding Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Sterile Compounding
1.2.3 Non-sterile Compounding
1.3 Market by Application
1.3.1 Global Bulk-Drug Compounding Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Prescription Drugs
1.3.3 Over-the-Counter Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bulk-Drug Compounding Market Perspective (2021–2032)
2.2 Global Bulk-Drug Compounding Growth Trends by Region
2.2.1 Global Bulk-Drug Compounding Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Bulk-Drug Compounding Historic Market Size by Region (2021–2026)
2.2.3 Bulk-Drug Compounding Forecasted Market Size by Region (2027–2032)
2.3 Bulk-Drug Compounding Market Dynamics
2.3.1 Bulk-Drug Compounding Industry Trends
2.3.2 Bulk-Drug Compounding Market Drivers
2.3.3 Bulk-Drug Compounding Market Challenges
2.3.4 Bulk-Drug Compounding Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bulk-Drug Compounding Players by Revenue
3.1.1 Global Top Bulk-Drug Compounding Players by Revenue (2021–2026)
3.1.2 Global Bulk-Drug Compounding Revenue Market Share by Players (2021–2026)
3.2 Global Top Bulk-Drug Compounding Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Bulk-Drug Compounding Revenue
3.4 Global Bulk-Drug Compounding Market Concentration Ratio
3.4.1 Global Bulk-Drug Compounding Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bulk-Drug Compounding Revenue in 2025
3.5 Global Key Players of Bulk-Drug Compounding Head Offices and Areas Served
3.6 Global Key Players of Bulk-Drug Compounding, Products and Applications
3.7 Global Key Players of Bulk-Drug Compounding, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Bulk-Drug Compounding Breakdown Data by Type
4.1 Global Bulk-Drug Compounding Historic Market Size by Type (2021–2026)
4.2 Global Bulk-Drug Compounding Forecasted Market Size by Type (2027–2032)
5 Bulk-Drug Compounding Breakdown Data by Application
5.1 Global Bulk-Drug Compounding Historic Market Size by Application (2021–2026)
5.2 Global Bulk-Drug Compounding Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Bulk-Drug Compounding Market Size (2021–2032)
6.2 North America Bulk-Drug Compounding Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Bulk-Drug Compounding Market Size by Country (2021–2026)
6.4 North America Bulk-Drug Compounding Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bulk-Drug Compounding Market Size (2021–2032)
7.2 Europe Bulk-Drug Compounding Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Bulk-Drug Compounding Market Size by Country (2021–2026)
7.4 Europe Bulk-Drug Compounding Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Bulk-Drug Compounding Market Size (2021–2032)
8.2 Asia-Pacific Bulk-Drug Compounding Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Bulk-Drug Compounding Market Size by Region (2021–2026)
8.4 Asia-Pacific Bulk-Drug Compounding Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Bulk-Drug Compounding Market Size (2021–2032)
9.2 Latin America Bulk-Drug Compounding Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Bulk-Drug Compounding Market Size by Country (2021–2026)
9.4 Latin America Bulk-Drug Compounding Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bulk-Drug Compounding Market Size (2021–2032)
10.2 Middle East & Africa Bulk-Drug Compounding Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Bulk-Drug Compounding Market Size by Country (2021–2026)
10.4 Middle East & Africa Bulk-Drug Compounding Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fogron
11.1.1 Fogron Company Details
11.1.2 Fogron Business Overview
11.1.3 Fogron Bulk-Drug Compounding Introduction
11.1.4 Fogron Revenue in Bulk-Drug Compounding Business (2021–2026)
11.1.5 Fogron Recent Development
11.2 B.Broun Melsungen AG
11.2.1 B.Broun Melsungen AG Company Details
11.2.2 B.Broun Melsungen AG Business Overview
11.2.3 B.Broun Melsungen AG Bulk-Drug Compounding Introduction
11.2.4 B.Broun Melsungen AG Revenue in Bulk-Drug Compounding Business (2021–2026)
11.2.5 B.Broun Melsungen AG Recent Development
11.3 Nephron Pharmaceuticals Corporaiton
11.3.1 Nephron Pharmaceuticals Corporaiton Company Details
11.3.2 Nephron Pharmaceuticals Corporaiton Business Overview
11.3.3 Nephron Pharmaceuticals Corporaiton Bulk-Drug Compounding Introduction
11.3.4 Nephron Pharmaceuticals Corporaiton Revenue in Bulk-Drug Compounding Business (2021–2026)
11.3.5 Nephron Pharmaceuticals Corporaiton Recent Development
11.4 Athenex Pharmaceutical Division
11.4.1 Athenex Pharmaceutical Division Company Details
11.4.2 Athenex Pharmaceutical Division Business Overview
11.4.3 Athenex Pharmaceutical Division Bulk-Drug Compounding Introduction
11.4.4 Athenex Pharmaceutical Division Revenue in Bulk-Drug Compounding Business (2021–2026)
11.4.5 Athenex Pharmaceutical Division Recent Development
11.5 QuVa Pharma
11.5.1 QuVa Pharma Company Details
11.5.2 QuVa Pharma Business Overview
11.5.3 QuVa Pharma Bulk-Drug Compounding Introduction
11.5.4 QuVa Pharma Revenue in Bulk-Drug Compounding Business (2021–2026)
11.5.5 QuVa Pharma Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Bulk-Drug Compounding Introduction
11.6.4 Fresenius Kabi Revenue in Bulk-Drug Compounding Business (2021–2026)
11.6.5 Fresenius Kabi Recent Development
11.7 Central Admixture Pharmacy Services Inc
11.7.1 Central Admixture Pharmacy Services Inc Company Details
11.7.2 Central Admixture Pharmacy Services Inc Business Overview
11.7.3 Central Admixture Pharmacy Services Inc Bulk-Drug Compounding Introduction
11.7.4 Central Admixture Pharmacy Services Inc Revenue in Bulk-Drug Compounding Business (2021–2026)
11.7.5 Central Admixture Pharmacy Services Inc Recent Development
11.8 PharMEDium
11.8.1 PharMEDium Company Details
11.8.2 PharMEDium Business Overview
11.8.3 PharMEDium Bulk-Drug Compounding Introduction
11.8.4 PharMEDium Revenue in Bulk-Drug Compounding Business (2021–2026)
11.8.5 PharMEDium Recent Development
11.9 Avella Speciality Pharmacy
11.9.1 Avella Speciality Pharmacy Company Details
11.9.2 Avella Speciality Pharmacy Business Overview
11.9.3 Avella Speciality Pharmacy Bulk-Drug Compounding Introduction
11.9.4 Avella Speciality Pharmacy Revenue in Bulk-Drug Compounding Business (2021–2026)
11.9.5 Avella Speciality Pharmacy Recent Development
11.10 ImprimisRx
11.10.1 ImprimisRx Company Details
11.10.2 ImprimisRx Business Overview
11.10.3 ImprimisRx Bulk-Drug Compounding Introduction
11.10.4 ImprimisRx Revenue in Bulk-Drug Compounding Business (2021–2026)
11.10.5 ImprimisRx Recent Development
11.11 Edge Pharma
11.11.1 Edge Pharma Company Details
11.11.2 Edge Pharma Business Overview
11.11.3 Edge Pharma Bulk-Drug Compounding Introduction
11.11.4 Edge Pharma Revenue in Bulk-Drug Compounding Business (2021–2026)
11.11.5 Edge Pharma Recent Development
11.12 SCA Pharma
11.12.1 SCA Pharma Company Details
11.12.2 SCA Pharma Business Overview
11.12.3 SCA Pharma Bulk-Drug Compounding Introduction
11.12.4 SCA Pharma Revenue in Bulk-Drug Compounding Business (2021–2026)
11.12.5 SCA Pharma Recent Development
11.13 New England Compounding Center
11.13.1 New England Compounding Center Company Details
11.13.2 New England Compounding Center Business Overview
11.13.3 New England Compounding Center Bulk-Drug Compounding Introduction
11.13.4 New England Compounding Center Revenue in Bulk-Drug Compounding Business (2021–2026)
11.13.5 New England Compounding Center Recent Development
11.14 Bellevue Pharmacy
11.14.1 Bellevue Pharmacy Company Details
11.14.2 Bellevue Pharmacy Business Overview
11.14.3 Bellevue Pharmacy Bulk-Drug Compounding Introduction
11.14.4 Bellevue Pharmacy Revenue in Bulk-Drug Compounding Business (2021–2026)
11.14.5 Bellevue Pharmacy Recent Development
11.15 Pharmazone
11.15.1 Pharmazone Company Details
11.15.2 Pharmazone Business Overview
11.15.3 Pharmazone Bulk-Drug Compounding Introduction
11.15.4 Pharmazone Revenue in Bulk-Drug Compounding Business (2021–2026)
11.15.5 Pharmazone Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Bulk-Drug Compounding Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Sterile Compounding
Table 3. Key Players of Non-sterile Compounding
Table 4. Global Bulk-Drug Compounding Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Bulk-Drug Compounding Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Bulk-Drug Compounding Market Size by Region (US$ Million), 2021–2026
Table 7. Global Bulk-Drug Compounding Market Share by Region (2021–2026)
Table 8. Global Bulk-Drug Compounding Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Bulk-Drug Compounding Market Share by Region (2027–2032)
Table 10. Bulk-Drug Compounding Market Trends
Table 11. Bulk-Drug Compounding Market Drivers
Table 12. Bulk-Drug Compounding Market Challenges
Table 13. Bulk-Drug Compounding Market Restraints
Table 14. Global Bulk-Drug Compounding Revenue by Players (US$ Million), 2021–2026
Table 15. Global Bulk-Drug Compounding Market Share by Players (2021–2026)
Table 16. Global Top Bulk-Drug Compounding Players by Tier (Tier 1, Tier 2, and Tier 3), based on Bulk-Drug Compounding Revenue, 2025
Table 17. Ranking of Global Top Bulk-Drug Compounding Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Bulk-Drug Compounding Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Bulk-Drug Compounding, Headquarters and Area Served
Table 20. Global Key Players of Bulk-Drug Compounding, Products and Applications
Table 21. Global Key Players of Bulk-Drug Compounding, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Bulk-Drug Compounding Market Size by Type (US$ Million), 2021–2026
Table 24. Global Bulk-Drug Compounding Revenue Market Share by Type (2021–2026)
Table 25. Global Bulk-Drug Compounding Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Bulk-Drug Compounding Revenue Market Share by Type (2027–2032)
Table 27. Global Bulk-Drug Compounding Market Size by Application (US$ Million), 2021–2026
Table 28. Global Bulk-Drug Compounding Revenue Market Share by Application (2021–2026)
Table 29. Global Bulk-Drug Compounding Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Bulk-Drug Compounding Revenue Market Share by Application (2027–2032)
Table 31. North America Bulk-Drug Compounding Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Bulk-Drug Compounding Market Size by Country (US$ Million), 2021–2026
Table 33. North America Bulk-Drug Compounding Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Bulk-Drug Compounding Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Bulk-Drug Compounding Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Bulk-Drug Compounding Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Bulk-Drug Compounding Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Bulk-Drug Compounding Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Bulk-Drug Compounding Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Bulk-Drug Compounding Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Bulk-Drug Compounding Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Bulk-Drug Compounding Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Bulk-Drug Compounding Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Bulk-Drug Compounding Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Bulk-Drug Compounding Market Size by Country (US$ Million), 2027–2032
Table 46. Fogron Company Details
Table 47. Fogron Business Overview
Table 48. Fogron Bulk-Drug Compounding Product
Table 49. Fogron Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 50. Fogron Recent Development
Table 51. B.Broun Melsungen AG Company Details
Table 52. B.Broun Melsungen AG Business Overview
Table 53. B.Broun Melsungen AG Bulk-Drug Compounding Product
Table 54. B.Broun Melsungen AG Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 55. B.Broun Melsungen AG Recent Development
Table 56. Nephron Pharmaceuticals Corporaiton Company Details
Table 57. Nephron Pharmaceuticals Corporaiton Business Overview
Table 58. Nephron Pharmaceuticals Corporaiton Bulk-Drug Compounding Product
Table 59. Nephron Pharmaceuticals Corporaiton Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 60. Nephron Pharmaceuticals Corporaiton Recent Development
Table 61. Athenex Pharmaceutical Division Company Details
Table 62. Athenex Pharmaceutical Division Business Overview
Table 63. Athenex Pharmaceutical Division Bulk-Drug Compounding Product
Table 64. Athenex Pharmaceutical Division Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 65. Athenex Pharmaceutical Division Recent Development
Table 66. QuVa Pharma Company Details
Table 67. QuVa Pharma Business Overview
Table 68. QuVa Pharma Bulk-Drug Compounding Product
Table 69. QuVa Pharma Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 70. QuVa Pharma Recent Development
Table 71. Fresenius Kabi Company Details
Table 72. Fresenius Kabi Business Overview
Table 73. Fresenius Kabi Bulk-Drug Compounding Product
Table 74. Fresenius Kabi Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 75. Fresenius Kabi Recent Development
Table 76. Central Admixture Pharmacy Services Inc Company Details
Table 77. Central Admixture Pharmacy Services Inc Business Overview
Table 78. Central Admixture Pharmacy Services Inc Bulk-Drug Compounding Product
Table 79. Central Admixture Pharmacy Services Inc Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 80. Central Admixture Pharmacy Services Inc Recent Development
Table 81. PharMEDium Company Details
Table 82. PharMEDium Business Overview
Table 83. PharMEDium Bulk-Drug Compounding Product
Table 84. PharMEDium Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 85. PharMEDium Recent Development
Table 86. Avella Speciality Pharmacy Company Details
Table 87. Avella Speciality Pharmacy Business Overview
Table 88. Avella Speciality Pharmacy Bulk-Drug Compounding Product
Table 89. Avella Speciality Pharmacy Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 90. Avella Speciality Pharmacy Recent Development
Table 91. ImprimisRx Company Details
Table 92. ImprimisRx Business Overview
Table 93. ImprimisRx Bulk-Drug Compounding Product
Table 94. ImprimisRx Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 95. ImprimisRx Recent Development
Table 96. Edge Pharma Company Details
Table 97. Edge Pharma Business Overview
Table 98. Edge Pharma Bulk-Drug Compounding Product
Table 99. Edge Pharma Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 100. Edge Pharma Recent Development
Table 101. SCA Pharma Company Details
Table 102. SCA Pharma Business Overview
Table 103. SCA Pharma Bulk-Drug Compounding Product
Table 104. SCA Pharma Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 105. SCA Pharma Recent Development
Table 106. New England Compounding Center Company Details
Table 107. New England Compounding Center Business Overview
Table 108. New England Compounding Center Bulk-Drug Compounding Product
Table 109. New England Compounding Center Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 110. New England Compounding Center Recent Development
Table 111. Bellevue Pharmacy Company Details
Table 112. Bellevue Pharmacy Business Overview
Table 113. Bellevue Pharmacy Bulk-Drug Compounding Product
Table 114. Bellevue Pharmacy Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 115. Bellevue Pharmacy Recent Development
Table 116. Pharmazone Company Details
Table 117. Pharmazone Business Overview
Table 118. Pharmazone Bulk-Drug Compounding Product
Table 119. Pharmazone Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
Table 120. Pharmazone Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Bulk-Drug Compounding Picture
Figure 2. Global Bulk-Drug Compounding Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Bulk-Drug Compounding Market Share by Type: 2025 vs 2032
Figure 4. Sterile Compounding Features
Figure 5. Non-sterile Compounding Features
Figure 6. Global Bulk-Drug Compounding Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Bulk-Drug Compounding Market Share by Application: 2025 vs 2032
Figure 8. Prescription Drugs Case Studies
Figure 9. Over-the-Counter Drugs Case Studies
Figure 10. Bulk-Drug Compounding Report Years Considered
Figure 11. Global Bulk-Drug Compounding Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Bulk-Drug Compounding Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Bulk-Drug Compounding Market Share by Region: 2025 vs 2032
Figure 14. Global Bulk-Drug Compounding Market Share by Players in 2025
Figure 15. Global Bulk-Drug Compounding Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Bulk-Drug Compounding Revenue in 2025
Figure 17. North America Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Bulk-Drug Compounding Market Share by Country (2021–2032)
Figure 19. United States Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Bulk-Drug Compounding Market Share by Country (2021–2032)
Figure 23. Germany Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Bulk-Drug Compounding Market Share by Region (2021–2032)
Figure 31. China Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Bulk-Drug Compounding Market Share by Country (2021–2032)
Figure 39. Mexico Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Bulk-Drug Compounding Market Share by Country (2021–2032)
Figure 43. Israel Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Fogron Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 47. B.Broun Melsungen AG Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 48. Nephron Pharmaceuticals Corporaiton Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 49. Athenex Pharmaceutical Division Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 50. QuVa Pharma Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 51. Fresenius Kabi Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 52. Central Admixture Pharmacy Services Inc Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 53. PharMEDium Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 54. Avella Speciality Pharmacy Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 55. ImprimisRx Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 56. Edge Pharma Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 57. SCA Pharma Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 58. New England Compounding Center Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 59. Bellevue Pharmacy Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 60. Pharmazone Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
